Assessing tumor heterogeneity and emergence mutations using next-generation sequencing for overcoming cancer drugs resistance
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessing tumor heterogeneity and emergence mutations using next-generation sequencing for overcoming cancer drugs resistance
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 12, Issue 10, Pages 1245-1248
Publisher
Informa UK Limited
Online
2012-11-26
DOI
10.1586/era.12.105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disrupting the Networks of Cancer
- (2012) D. F. Camacho et al. CLINICAL CANCER RESEARCH
- Disrupting cancer cells’ biocircuits with interactome-based drugs: is ‘clinical’ innovation realistic?
- (2012) Dimitrios H Roukos Expert Review of Proteomics
- Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer
- (2012) Daniel J. Sargent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differential network biology
- (2012) Trey Ideker et al. Molecular Systems Biology
- Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
- (2012) Arvin C. Dar et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Winning the War: Science Parkour
- (2012) B. Vogelstein et al. Science Translational Medicine
- Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges
- (2012) Purvesh Khatri et al. PLoS Computational Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
- (2011) Timothy S Maughan et al. LANCET
- Networks medicine: from reductionism to evidence of complex dynamic biomolecular interactions
- (2011) Dimitrios H Roukos PHARMACOGENOMICS
- Exploring the Genomes of Cancer Cells: Progress and Promise
- (2011) M. R. Stratton SCIENCE
- Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice
- (2010) Dimitrios H Roukos Biomarkers in Medicine
- Genotype–phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment
- (2010) Dimitrios H Roukos et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Network medicine: a network-based approach to human disease
- (2010) Albert-László Barabási et al. NATURE REVIEWS GENETICS
- Individual genomes and personalized medicine: life diversity and complexity
- (2010) Christos Katsios et al. Personalized Medicine
- Complete genome sequencing and network modeling to overcome trastuzumab resistance
- (2010) Dimitrios H Roukos PHARMACOGENOMICS
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search